Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities.

Jeyakumar M, Carlson KE, Gunther JR, Katzenellenbogen JA.

J Biol Chem. 2011 Apr 15;286(15):12971-82. doi: 10.1074/jbc.M110.205112. Epub 2011 Feb 14.

2.

Regulation of specific target genes and biological responses by estrogen receptor subtype agonists.

Leitman DC, Paruthiyil S, Vivar OI, Saunier EF, Herber CB, Cohen I, Tagliaferri M, Speed TP.

Curr Opin Pharmacol. 2010 Dec;10(6):629-36. doi: 10.1016/j.coph.2010.09.009. Epub 2010 Oct 14. Review.

3.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
4.

Estrogen receptors (ERα versus ERβ): friends or foes in human biology?

Planey SL, Kumar R, Arnott JA.

J Recept Signal Transduct Res. 2014 Feb;34(1):1-5. doi: 10.3109/10799893.2013.853188. Epub 2013 Nov 4. Review.

PMID:
24188405
5.

Estrogen receptors: selective ligands, partners, and distinctive pharmacology.

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA.

Recent Prog Horm Res. 2000;55:163-93; discussion 194-5. Review.

PMID:
11036937
6.

Estrogen receptor beta: an overview and update.

Zhao C, Dahlman-Wright K, Gustafsson JA.

Nucl Recept Signal. 2008 Feb 1;6:e003. doi: 10.1621/nrs.06003. Review.

7.

Estrogen signaling via estrogen receptor {beta}.

Zhao C, Dahlman-Wright K, Gustafsson JÅ.

J Biol Chem. 2010 Dec 17;285(51):39575-9. doi: 10.1074/jbc.R110.180109. Epub 2010 Oct 18. Review.

8.

Estrogen receptor α and β in the normal immune system and in lymphoid malignancies.

Yakimchuk K, Jondal M, Okret S.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):121-9. doi: 10.1016/j.mce.2013.05.016. Epub 2013 May 23. Review.

PMID:
23707618
9.

Selectively targeting estrogen receptors for cancer treatment.

Shanle EK, Xu W.

Adv Drug Deliv Rev. 2010 Oct 30;62(13):1265-76. doi: 10.1016/j.addr.2010.08.001. Epub 2010 Aug 10. Review.

10.

Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways.

Katzenellenbogen BS.

J Soc Gynecol Investig. 2000 Jan-Feb;7(1 Suppl):S33-7. Review.

PMID:
10732327
11.
12.

Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

Pastore MB, Jobe SO, Ramadoss J, Magness RR.

Semin Reprod Med. 2012 Jan;30(1):46-61. doi: 10.1055/s-0031-1299597. Epub 2012 Jan 23. Review.

13.

Estrogen Receptor Ligands: A Review (2013-2015).

Farzaneh S, Zarghi A.

Sci Pharm. 2016 Apr 13;84(3):409-427. doi: 10.3390/scipharm84030409. Review.

14.

Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha.

Imai Y, Kondoh S, Kouzmenko A, Kato S.

Mol Endocrinol. 2010 May;24(5):877-85. doi: 10.1210/me.2009-0238. Epub 2009 Nov 12. Review.

15.

Contributions of estrogen receptor-α and estrogen receptor-ß to the regulation of behavior.

Tetel MJ, Pfaff DW.

Biochim Biophys Acta. 2010 Oct;1800(10):1084-9. doi: 10.1016/j.bbagen.2010.01.008. Epub 2010 Jan 25. Review.

16.

Regulation of estrogen receptor beta activity and implications in health and disease.

Swedenborg E, Power KA, Cai W, Pongratz I, Rüegg J.

Cell Mol Life Sci. 2009 Dec;66(24):3873-94. doi: 10.1007/s00018-009-0118-z. Review.

PMID:
19669093
17.

In vivo potency revisited - Keep the target inl sight.

Gabrielsson J, Peletier LA, Hjorth S.

Pharmacol Ther. 2017 Oct 9. pii: S0163-7258(17)30248-6. doi: 10.1016/j.pharmthera.2017.10.011. [Epub ahead of print] Review.

PMID:
29024741

Supplemental Content

Support Center